Enhua Pharmaceutical Chemical "Lipeketone Tablets" through the conformity evaluation of generic drugs

recently, Enhua Pharmaceuticals received the "Drug Supplementary Application Approval" approved by the StateMedicines(http://Supervision Authority for the approval of the chemical "Lipeketone Tablets", which was evaluated by theof the(http:// of thePharmaceuticalsLipeketone tablets are used to treat acute and chronic schizophrenia and other psychiatric conditions with obvious positive symptoms (e.ghallucinations, fantasies, mood disorders, hostility, suspicion) and obvious negative symptoms (e.gretardation, emotional apathy, and social indifference, whispering)It can also alleviate the emotional symptoms associated with schizophrenia (e.gdepression, guilt, anxiety)For patients with effective acute treatment, lipeone can continue to play its clinical efficacy in the maintenance period therapyThe announcement also revealed that, so far, thecompany(http://in the libione tablet consistency evaluation project has invested about 8.6 million yuan in research and development costs 　　General name of the drug: Lipeketone tablets, commodity name: Silishu dosage form: tablet specifications: 1mg
Application: domestic drug registration registration classification: chemical declaration stage: consistency evaluation applicant: Jiangsu Enhua Pharmaceutical Co., Ltd approval conclusion: after examination, this product through the quality and efficacy consistency evaluation of generic drugs